Universite Paris Cite Researchers Yield New Study Findings on Multiple Myeloma (Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma).
Předmět: | |
---|---|
Zdroj: | Hematology Week; 2/13/2023, p1100-1100, 1p |
Databáze: | Complementary Index |
Externí odkaz: |